We are making history at Groff North America. After 53 years, we are one of five companies approved to grow and study cannabis for medical research in the U.S. WPMT FOX43 took a closer look at our role in ending the monopoly over federal legal cannabis production Click Here To Watch!
We are making history at Groff North America!
PUBLISHED Mar 03, 2022
Suggested reads
Apr 20, 2022
Can DEA-backed cannabis growers strike gold via drug development?
Can DEA-backed cannabis growers strike gold via drug development?
The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida
Read more
Mar 31, 2022
Groff North America partners with Pennsylvania college for first-of-its-kind cannabinoid major
FOR IMMEDIATE RELEASE
CONTACT: Amanda Peterson Martin
apmartin@gavinadv.com
484-949-1320
Groff North America partners with Pennsylvania college for first
Read more
Mar 04, 2022
How will Groff North America cannabis products be developed from research to market as medicines?
How will Groff North America cannabis products be developed from research to market as medicines? CEO Joe Gryzb talked to Harri Leigh of WPMT FOX43 about the potenti
Read more
Mar 02, 2022
The transition from medical marijuana to cannabis-based pharmaceutical drugs | Little Green Pill
We know cannabis has powerful potential medical effects. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field
Read more